Search

Your search keyword '"Amiot, A"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Amiot, A" Remove constraint Author: "Amiot, A" Journal gastroenterology Remove constraint Journal: gastroenterology
105 results on '"Amiot, A"'

Search Results

1. Mo1565: EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH CHRONIC ACTIVE POUCHITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

2. Su1503: REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT

3. Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

5. 1178 PROMISING EFFICACY OF SMALL MOLECULES AND BIOLOGICALS FOR MICROSCOPIC COLITIS: RESULTS FROM A LARGE REAL-LIFE MULTICENTER COHORT

7. Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II

8. Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

9. Mo1565: EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH CHRONIC ACTIVE POUCHITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

10. 457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDY

11. Sa554 CHRONIC POUCHITIS AND CROHN'S DISEASE OF THE POUCH AFTER ILEAL POUCH-ANAL ANASTOMOSIS : INCIDENCE AND RISK FACTORS

12. Sa1820 RISK OF INCIDENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH PRIOR BREAST CANCER : A MULTICENTRE COHORT STUDY

13. Sa1772 DIETARY INDEX BASED ON THE FOOD STANDARD AGENCY NUTRIENT PROFILING SYSTEM AND RISK OF CROHN'S DISEASE AND ULCERATIVE COLITIS: A EUROPEAN PROSPECTIVE COHORT STUDY

15. Sa1744 IMPACT OF LINE OF THERAPY, THERAPEUTIC ESCALATION OR DE-ESCALATION ON ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SUB-ANALYSIS FROM THE PROSPECTIVE NATIONWIDE STUDY ACCEPT2.

16. Sa1743 ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE NATIONWIDE STUDY (ACCEPT2).

17. Sa554 CHRONIC POUCHITIS AND CROHN'S DISEASE OF THE POUCH AFTER ILEAL POUCH-ANAL ANASTOMOSIS : INCIDENCE AND RISK FACTORS

18. 457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDY

19. Sa1743 ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE NATIONWIDE STUDY (ACCEPT2)

20. Sa1744 IMPACT OF LINE OF THERAPY, THERAPEUTIC ESCALATION OR DE-ESCALATION ON ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SUB-ANALYSIS FROM THE PROSPECTIVE NATIONWIDE STUDY ACCEPT2

21. Mo1800 – A Simple Scoring Tool Predicts Exposure-Response Relationship, Onset of Action, Response to Interval Shortening, and Surgical Risk with Vedolizumab Therapy for Crohn’s Disease

22. Mo1800 – A Simple Scoring Tool Predicts Exposure-Response Relationship, Onset of Action, Response to Interval Shortening, and Surgical Risk with Vedolizumab Therapy for Crohn’s Disease

23. Mo1873 - Efficacy of Infliximab after Failure of Subcutaneous Antitnf Agent in Patients with Ulcerative Colitis: A Multicenter Study

24. Mo1785 - Long-Term Outcome of Crohn's Disease Complicated by Upper Gastrointestinal Stricture: A Getaid Cohort Study

25. Mo1785 - Long-Term Outcome of Crohn's Disease Complicated by Upper Gastrointestinal Stricture: A Getaid Cohort Study

26. Mo1873 - Efficacy of Infliximab after Failure of Subcutaneous Antitnf Agent in Patients with Ulcerative Colitis: A Multicenter Study

27. Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid

28. Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid

29. Mo1896 The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study

31. 313 Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease

32. 1121 Autoimmune Pancreatitis Associated With Inflammatory Bowel Disease: A Multicentric Study of the GETAID

33. Sa1949 A Negative Screening Does Not Eliminate Tuberculosis Risk Under Anti-TNF Treatment in Inflammatory Bowel Disease: A Descriptive Study

34. 1072 Rate and Predictors of Mucosal Healing in Patients With Ulcerative Colitis Treated With Thiopurines: Results of a Multicentric Cohort Study

35. 1121 Autoimmune Pancreatitis Associated With Inflammatory Bowel Disease: A Multicentric Study of the GETAID

36. 313 Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease

37. Mo1896 The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study

38. Sa1949 A Negative Screening Does Not Eliminate Tuberculosis Risk Under Anti-TNF Treatment in Inflammatory Bowel Disease: A Descriptive Study

39. 595 Ustekinumab Efficacy and Safety in Crohn's Disease Patients Refractory to Conventional and Anti-TNF Therapy: A Multicenter Retrospective Experience

41. Su1229 Definitions of the Endoscopic Lesions in Crohn's Disease: Reproductibility Study and GETAID Expert Consensus

42. 829 Long-Term Outcomes in a Cohort of Patients With Acute Severe Ulcerative Colitis Refractory to Intravenous Steroids Treated With Cyclosporine or Infliximab

43. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction

44. 829 Long-Term Outcomes in a Cohort of Patients With Acute Severe Ulcerative Colitis Refractory to Intravenous Steroids Treated With Cyclosporine or Infliximab

45. Mo1939 Performance of a Blood Methylated Mutitarget DNA Test (Colohybritest) for the Diagnosis of Colorectal (CRC) Cancer: A Transversal Study on 878 Individuals

46. 595 Ustekinumab Efficacy and Safety in Crohn's Disease Patients Refractory to Conventional and Anti-TNF Therapy: A Multicenter Retrospective Experience

47. Su1229 Definitions of the Endoscopic Lesions in Crohn's Disease: Reproductibility Study and GETAID Expert Consensus

48. 553 Risk of Dysplasia and Cancer Complicating Colonic Strictures in Inflammatory Bowel Disease: A GETAID Study

50. 341 Risk of Incident Cancer in Patients With Inflammatory Bowel Disease Starting Anti-TNF Therapy While Having Prior Malignancy Within Past 5 Years

Catalog

Books, media, physical & digital resources